These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 8589304

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effect of Rhizoma Polygoni Cuspidati and Ramulus Cinnamomi compatibility on uric acid metabolism and urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 in rats with hyperuricemia.
    Han B, Zhu CX, Shi W, Huang HZ, Hu XG, Zhou XM, Lei M, Li Z.
    Chin J Integr Med; 2017 Jul; 23(7):535-542. PubMed ID: 28116659
    [Abstract] [Full Text] [Related]

  • 24. Intrinsic renal disease leading to abnormal urate excretion.
    Rieselbach RE, Steele TH.
    Nephron; 1975 Jul; 14(1):81-7. PubMed ID: 1124138
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Mangiferin Inhibits Renal Urate Reabsorption by Modulating Urate Transporters in Experimental Hyperuricemia.
    Yang H, Gao L, Niu Y, Zhou Y, Lin H, Jiang J, Kong X, Liu X, Li L.
    Biol Pharm Bull; 2015 Jul; 38(10):1591-8. PubMed ID: 26228630
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Uric acid--a uremic toxin?
    Nakagawa T, Mazzali M, Kang DH, Sánchez-Lozada LG, Herrera-Acosta J, Johnson RJ.
    Blood Purif; 2006 Jul; 24(1):67-70. PubMed ID: 16361844
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Marked elevation in cortical urate and xanthine oxidoreductase activity in experimental bacterial meningitis.
    Christen S, Bifrare YD, Siegenthaler C, Leib SL, Täuber MG.
    Brain Res; 2001 May 11; 900(2):244-51. PubMed ID: 11334804
    [Abstract] [Full Text] [Related]

  • 36. Dual actions of norathyriol as a new candidate hypouricaemic agent: uricosuric effects and xanthine oxidase inhibition.
    Lin H, Tu C, Niu Y, Li F, Yuan L, Li N, Xu A, Gao L, Li L.
    Eur J Pharmacol; 2019 Jun 15; 853():371-380. PubMed ID: 31009635
    [Abstract] [Full Text] [Related]

  • 37. [Gout: an overview of available urate lowering therapies].
    Richette P.
    Ann Pharm Fr; 2012 May 15; 70(3):133-8. PubMed ID: 22655581
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.